Skip to main content

For healthcare professionals and researchers only. ClinicalMind content does not constitute clinical guidance, diagnosis, or treatment advice. See full disclaimer

ClinicalMind logoClinicalMind
  • Clinical Applications
  • Research & Evidence
  • Regulatory & Policy
  • Policy Tracker
  • Company Profiles
  • Glossary
  • Log In
  • Sign Up
  • Clinical Applications
  • Research & Evidence
  • Regulatory & Policy
  • Policy Tracker
  • Company Profiles
  • Glossary
  • Search
  • Log In
  • Sign Up
  1. Home
  2. Clinical Applications
  3. Can AI Improve Substance Abuse Surveillance? The Evidence So Far
Can AI Improve Substance Abuse Surveillance? The Evidence So Far
Addiction medicineNatural Language Processing, Machine Learning

Can AI Improve Substance Abuse Surveillance? The Evidence So Far

This article examines four AI-based surveillance modalities for tracking substance abuse at the population level—EMS narrative NLP classifiers, wastewater analysis, PDMP-integrated machine learning scores, and social media language models—and evaluates the evidence quality, limitations, and privacy concerns for each approach.

By Editorial TeamUpdated Jul 21, 2026
  • medical imaging
  • radiology AI
  • pathology AI
  • cardiology AI
  • ambient documentation
  • clinical decision support
  • sepsis prediction
  • NLP in clinical workflows
  • AI scribes
  • drug discovery
  • oncology AI
  • primary care AI
  • emergency medicine AI
  • ophthalmology AI
  • dermatology AI

Evidence & Regulatory Summary

Clinical Specialty
Addiction medicine
AI Approach
Natural Language Processing, Machine Learning
Evidence Quality
Retrospective single-center studies
Known Limitations
Privacy concerns, dataset bias, unvalidated performance for PDMP and social media analysis

Related Content

Related Research

  • Archives of Pathology and Laboratory MedicinePaige Prostate AI: A Critical Appraisal of the Raciti et al. 2023 Pivotal Clinical Validation Study
  • npj Digital MedicineAI in Computational Pathology: What the First Cross-Disease Systematic Review of Whole Slide Image Diagnostics Actually Shows

Company Profiles

  • iCAD ProFound AI Mammography: FDA Clearance History and Device Record
  • Caption AI Cardiac Ultrasound: FDA Authorization History, Clinical Validation, and Technology Profile

Related Applications

  • AI Sepsis Prediction in Hospitals: Epic Sepsis Model Evidence, Alert Burden, and FDA-Cleared Alternatives
  • Ambient AI Scribes in Epic EHR: Real-World Deployment Evidence and Clinical Governance
  • AI for Health: A Clinical Application Brief Across Key Medical Domains
← All Clinical Applications← Addiction medicine entries

Discussion

Reminder: Comments do not constitute clinical guidance. Please do not share patient-identifiable information. ClinicalMind is not a clinical consultation channel.

Comments

Join the discussion with an anonymous comment.

Loading comments...
ClinicalMind

Rigorous coverage of AI in healthcare — evidence, regulation, clinical applications, and industry intelligence for healthcare professionals and researchers.

Content Areas

  • Clinical Applications
  • Research & Evidence
  • Regulatory & Policy
  • Policy Tracker
  • Company Profiles
  • Glossary
  • Education & Courses
  • Industry Intelligence
  • About
  • Contact
  • Newsletter

Editorial Standards

ClinicalMind sources its content from peer-reviewed literature, primary regulatory documents (FDA, CMS, WHO, CHAI, EMA), and independently verified sources. Content does not constitute clinical guidance, diagnosis, treatment recommendations, or medication advice. Readers must consult qualified healthcare professionals for all clinical decisions.

Company profiles carry a Profile Last Verified date. Policy Tracker entries link directly to primary regulatory sources. Market figures are cited with source organization and methodology caveats. Vendor-supplied data is distinguished from independently corroborated evidence.

  • Privacy Policy
  • Terms of Use
  • Disclaimer

© 2026 ClinicalMind. For healthcare professionals and researchers. Not clinical guidance.

Blogarama - Blog Directory